Today’s top gainers include the company Illumina Inc. (NASDAQ:ILMN) which is in the industry Biotechnology, gaining -0.72% today. In the last week its performance is 4.28%, and -19.16% for the past quarter. Currently, Illumina Inc., ILMN has a target price of 154.9, so today’s gain of -0.72% is a significant step towards its target price. The GAP today is therefore -0.18%.
Illumina Inc. (NASDAQ:ILMN), has a market cap of 20672.19, and is based in USA. Insider ownership is at 1.20%, and institutional ownership is 96.70%.
At the current price of 139.77, it has a dividend yield of *TBA, and its target price is 154.9. This is with a profit margin of 18.40%, and total debt/equity of 0.51. Illumina Inc. (NASDAQ:ILMN) has a P/E of 50.63, as well as a forward P/E of 35.3.
With a current EPS of 2.78, and a forecasted EPS growth for next year at 18.09%,Illumina Inc. (NASDAQ:ILMN) has had a EPS growth for the past five years at 28.90%. For the next five years EPS growth is projected to be 15.80%.
Performance for the year is -36.52%. Since its IPO date on 7/28/2000, the total performance to date is -26.65%.
Volume today for Illumina Inc. (NASDAQ:ILMN), is 248885, while its average volume is 1440.2. Whilst the total gain today was -0.72%, it did have a day high of -6.09%.
Volatility for this week has been at 3.24%, and 2.92% for the month. The 52-week low for Illumina Inc., ILMN has been 9.97%, while the 52-week-high has reached -42.33%.
Looking at its return of investments, which is 16.60%, and its return on assets is 11.10%. Illumina Inc. (NASDAQ:ILMN) has an operating margin of 24.80%. With a sales growth of 6.20% quarter over quarter. Bearing in mind that Illumina Inc., ILMN is in the sector Healthcare, its long-term debt/equity is 0.51, and has a current ratio of 4.3 and 3.7 for quick ratio.
So what is the value of Illumina Inc.? Well its PEG is 3.2, and the P/S is 9.18, along with a P/B of 10.38. Meanwhile it has a p/cash of 15.39.